SEC Tracker
Get the app

Disc Medicine IRON

Disc Medicine raises $422.4M in stock offering

Item 1.01 Enters material agreement, Item 2.02 Reports results, Item 8.01 Other events

Form
8-K
Filed
Importance
Major
  1. Offering of 6M shares at $75 each
  2. Underwriters may buy 900K additional shares
  3. Net proceeds expected to be $422.4M
  4. Cash runway extends to 2030

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Disc Medicine files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Arrowhead Pharmaceuticals ARWR public float $1.4B, Mar 31, 2025, over 18 months old
  2. Adaptive Biotechnologies ADPT public float $1.4B, Jun 30, 2025
  3. Travere Therapeutics TVTX public float $1.3B, Jun 30, 2025
  4. Ani Pharmaceuticals ANIP public float $1.3B, Jun 30, 2025
  5. Celldex Therapeutics CLDX public float $1.3B, Jun 30, 2025